We recently published a list of 13 AI News and Ratings You Probably Missed. In this article, we are going to take a look at where Advanced Micro Devices, Inc. (NASDAQ:AMD) stands against other AI stocks.
As per a CNBC report, in 2025, significant changes are expected in global AI regulation, especially in the U.S., the EU, and the UK. President-elect Donald Trump, who is supported by business leaders like Elon Musk, may influence AI policies, with Musk’s experience in AI raising expectations for U.S. advancements. In Europe, the EU’s AI Act has introduced comprehensive regulations, but tensions with U.S. tech companies are still there over its strict measures.
Meanwhile, the U.K. is considering a more flexible, principles-based approach, especially regarding the use of copyrighted content for AI training. Additionally, U.S. and China relations could affect global AI development, with both countries competing for AI dominance and potentially creating safety regulations to prevent uncontrolled AI advancements.
AI is driving a major transformation in technology as significant investments are being funneled into infrastructure, data centers, and the AI value chain. Companies are rapidly building out AI infrastructure, with an increasing focus on supply chain components beyond just semiconductors, which highlight potential profits in sectors like memory, cooling, and fiber optics.
Jon McNeill, co-founder of Vistashares, discussed the impact of AI infrastructure on investment opportunities in an interview with Romaine Bostick and Scarlet Fu of Bloomberg. He explained that while AI’s impact on data centers is often discussed in terms of semiconductors, the actual supply chain involves different elements, such as memory, cooling, and fiber optics. McNeill emphasized the potential for profits in the AI supply chain, especially for investors looking beyond the major producers to lesser-known companies.
He also addressed the risks of international investments and noted that while the U.S. dominates the AI sector, Asia is rapidly building its own AI infrastructure. McNeill highlighted the growing value of AI applications in autonomous driving and robotics, which could drive significant economic growth. He pointed to large investments in data centers, such as AWS’ $11 billion investment in Georgia, as signs that this growth will continue, with the major tech companies leading the charge in the AI race.
For this article, we selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s database of 900 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
AMD (AMD) Invests in Absci for AI-Driven Drug Discovery with High-Performance Computing Solutions
A close up of a complex looking PCB board with several intergrated semiconductor parts.
Advanced Micro Devices, Inc. (NASDAQ:AMD) is known for its semiconductor products, delivering processors and graphics units for data centers, gaming, and embedded systems. The company specializes in high-performance computing solutions designed for AI-driven applications.
On January 8, AMD entered a strategic collaboration with Absci Corporation, including a $20 million investment to support the company’s AI-driven drug discovery efforts. By providing AMD Instinct accelerators and ROCm software, AMD is looking to help Absci optimize its AI solutions for biologic drug development, particularly in antibody design.
The partnership will allow Absci to accelerate the creation of next-generation therapeutics while benefiting from AMD’s high-performance computing capabilities. Mark Papermaster, AMD’s CTO, highlighted that the collaboration aligns with AMD’s mission to power demanding AI workloads in innovative fields like drug discovery. He said:
“We are proud to partner with Absci, a company at the forefront of AI-driven drug discovery, to help further accelerate breakthroughs in therapeutics and transform how biologic drugs are developed… Absci’s groundbreaking work in AI drug discovery is a perfect fit for AMD high-performance computing solutions and software, designed for the most demanding AI workloads.”
Overall, AMD ranks 6th on our list of AI news and ratings you probably missed. While we acknowledge the potential of AMD as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AMD but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
